1834 Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

1834 Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-400	Closed	-$61K	–	457
2021 Q4	$61K	Hold	400	–	–	0.01%	255
2021 Q3	$65K	Hold	400	–	–	0.01%	258
2021 Q2	$65K	Buy	+400	New	+$61.6K	0.01%	256
2020 Q1	–	Sell	-99	Closed	-$12K	–	419
2019 Q4	$12K	Buy	+99	New	+$11K	﹤0.01%	365
2019 Q3	–	Sell	-135	Closed	-$15K	–	473
2019 Q2	$15K	Sell	135 -3,140	-96%	-$334K	﹤0.01%	348
2019 Q1	$366K	Sell	3,275 -17,587	-84%	-$1.93M	0.06%	135
2018 Q4	$2.01M	Sell	20,862 -14,829	-42%	-$1.57M	0.34%	74
2018 Q3	$4.35M	Buy	35,691 +1,044	+3%	+$123K	0.64%	57
2018 Q2	$3.81M	Sell	34,647 -964	-3%	-$103K	0.6%	59
2018 Q1	$3.8M	Buy	35,611 +346	+1%	+$38.4K	0.65%	54
2017 Q4	$3.77M	Sell	35,265 -1,122	-3%	-$120K	0.59%	61
2017 Q3	$4.05M	Buy	36,387 +5,328	+17%	+$569K	0.76%	50
2017 Q2	$3.21M	Buy	+31,059	New	+$3.06M	0.61%	57
2015 Q4	–	Sell	-9,591	Closed	-$970K	–	183
2015 Q3	$970K	Sell	9,591 -1,380	-13%	-$166K	0.24%	95
2015 Q2	$1.35M	Sell	10,971 -2,730	-20%	-$327K	0.37%	66
2015 Q1	$1.57M	Sell	13,701 -225	-2%	-$24.8K	0.43%	64
2014 Q4	$1.41M	Sell	13,926 -2,100	-13%	-$204K	0.39%	68
2014 Q3	$1.46M	Sell	16,026 -1,350	-8%	-$118K	0.4%	67
2014 Q2	$1.49M	Buy	+17,376	New	+$1.37M	0.4%	68

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

1834 Investment Advisors's IBB Position: Q1 2022 in Review

1834 Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 400 shares — an estimated $61K sold.

1834 Investment Advisors first reported a position in IBB in Q2 2014 and held it in 19 quarters. The position peaked at $4.35M in Q3 2018. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

1834 Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
1834 Investment Advisors sold 400 iShares Biotechnology ETF shares in Q1 2022, an estimated $61K.
1834 Investment Advisors first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 19 quarters.
1834 Investment Advisors's iShares Biotechnology ETF position peaked at $4.35M in Q3 2018.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on 1834 Investment Advisors's 13F filing for Q1 2022, filed 24 May 2022.